Clinical trial
Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune…
NCT00031291 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00031291 |
|---|---|
| Title | Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin |
| Official title | Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Anthrax |
| Intervention type | Drug |
| Interventions | Anthrax Immune Globulin |
| Enrollment | 400 |
| Start date | Feb 1, 2002 |
| Completion | Mar 1, 2004 |
| First posted | Mar 1, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: